The effect of oral anticoagulation on clotting during hemodialysis. Background Between 5%
and 10% of hemodialysis patients are treated with oral anticoagulants. It is currently …

Background. A single bolus dose of LMW heparin at the start of haemodialysis effectively
prevents clot formation in the dialyser and bubble trap. However, there are few studies on …

Background. A single bolus of dalteparin at the start of haemodialysis (HD) may prevent clot
formation, but subclinical activation of platelets and coagulation may still occur …

Background Anticoagulation for the haemodialysis circuit in patients treated with oral
anticoagulation poses additional haemorrhagic risk. The few available data suggest that …

Background: Low-molecular-weight heparins are being increasingly used as an alternative
to unfractionated heparin for anticoagulation of the haemodialysis (HD) circuit. Data on …

The coagulation cascade is complex but well studied. Dialysis membranes and lines are
inherently pro‐coagulant and activate both the intrinsic and extrinsic pathways of …

Background During haemodialysis, anticoagulants are required to prevent clotting in the
extracorporeal circuit. Low-molecular weight heparins (LMWH) are frequently used because …

Appropriate anticoagulation for hemodialysis (HD) requires a subtle balance between under‐
and over‐heparinization to prevent extracorporeal circuit (ECC) clotting and bleeding …

Background: Low-molecular-weight heparin (LMWH) is supposed to be advantageous
compared to unfractionated heparin for chronic hemodialysis (HD) with respect to lipid and …

Background: Heparin-free dialysis (HFD), ie only priming of the dialyser and no systemic
heparinization, might reduce the risk of bleeding in dialysis patients receiving oral …